A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide

Diane Thiboutot, Lawrence Eichenfield, Alan Shalita, James Q. Del Rosso, Leonard Swinyer, Emil Tanghetti, Eduardo Tschen, Lisa Parr

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A 3-step acne system has been developed to enhance the bioavailability and follicular penetration of benzoyl peroxide (BPO). Participants with mild to moderate facial acne vulgaris were randomly assigned to 10 weeks' facial treatment with the 3-step acne system (proprietary salicylic acid cleanser 2% twice daily, proprietary salicylic acid toner 2% once daily, and solubilized BPO gel 5% twice daily) or with control cleanser twice daily plus clindamycin 1%-BPO 5% gel (jar formulation) twice daily. Among 139 participants enrolled, the 3-step acne system was at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic (mean reductions were 27% vs 13%, 39% vs 25%, 40% vs 33%, and 42% vs 42% at weeks 2, 4, 6, and 10, respectively)(all not significant). Both regimens were associated with comparable reductions in inflammatory lesion counts at all time points. Both regimens also were generally well-tolerated with mean scores for erythema, dryness, peeling, burning/stinging, and itching less than mild in both groups at all time points. The 3-step acne system is at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic, which is likely attributed to the solubilized BPO formulation.

Original languageEnglish (US)
Pages (from-to)48-55
Number of pages8
JournalCutis
Volume84
Issue number1
StatePublished - Jul 1 2009

Fingerprint

Benzoyl Peroxide
Clindamycin
Acne Vulgaris
Salicylic Acid
Gels
Anti-Bacterial Agents
Erythema
Pruritus
Biological Availability

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Thiboutot, D., Eichenfield, L., Shalita, A., Del Rosso, J. Q., Swinyer, L., Tanghetti, E., ... Parr, L. (2009). A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Cutis, 84(1), 48-55.
Thiboutot, Diane ; Eichenfield, Lawrence ; Shalita, Alan ; Del Rosso, James Q. ; Swinyer, Leonard ; Tanghetti, Emil ; Tschen, Eduardo ; Parr, Lisa. / A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. In: Cutis. 2009 ; Vol. 84, No. 1. pp. 48-55.
@article{17d46b523d124fe99eb22758dc99b94d,
title = "A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide",
abstract = "A 3-step acne system has been developed to enhance the bioavailability and follicular penetration of benzoyl peroxide (BPO). Participants with mild to moderate facial acne vulgaris were randomly assigned to 10 weeks' facial treatment with the 3-step acne system (proprietary salicylic acid cleanser 2{\%} twice daily, proprietary salicylic acid toner 2{\%} once daily, and solubilized BPO gel 5{\%} twice daily) or with control cleanser twice daily plus clindamycin 1{\%}-BPO 5{\%} gel (jar formulation) twice daily. Among 139 participants enrolled, the 3-step acne system was at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic (mean reductions were 27{\%} vs 13{\%}, 39{\%} vs 25{\%}, 40{\%} vs 33{\%}, and 42{\%} vs 42{\%} at weeks 2, 4, 6, and 10, respectively)(all not significant). Both regimens were associated with comparable reductions in inflammatory lesion counts at all time points. Both regimens also were generally well-tolerated with mean scores for erythema, dryness, peeling, burning/stinging, and itching less than mild in both groups at all time points. The 3-step acne system is at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic, which is likely attributed to the solubilized BPO formulation.",
author = "Diane Thiboutot and Lawrence Eichenfield and Alan Shalita and {Del Rosso}, {James Q.} and Leonard Swinyer and Emil Tanghetti and Eduardo Tschen and Lisa Parr",
year = "2009",
month = "7",
day = "1",
language = "English (US)",
volume = "84",
pages = "48--55",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "1",

}

Thiboutot, D, Eichenfield, L, Shalita, A, Del Rosso, JQ, Swinyer, L, Tanghetti, E, Tschen, E & Parr, L 2009, 'A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide', Cutis, vol. 84, no. 1, pp. 48-55.

A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. / Thiboutot, Diane; Eichenfield, Lawrence; Shalita, Alan; Del Rosso, James Q.; Swinyer, Leonard; Tanghetti, Emil; Tschen, Eduardo; Parr, Lisa.

In: Cutis, Vol. 84, No. 1, 01.07.2009, p. 48-55.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide

AU - Thiboutot, Diane

AU - Eichenfield, Lawrence

AU - Shalita, Alan

AU - Del Rosso, James Q.

AU - Swinyer, Leonard

AU - Tanghetti, Emil

AU - Tschen, Eduardo

AU - Parr, Lisa

PY - 2009/7/1

Y1 - 2009/7/1

N2 - A 3-step acne system has been developed to enhance the bioavailability and follicular penetration of benzoyl peroxide (BPO). Participants with mild to moderate facial acne vulgaris were randomly assigned to 10 weeks' facial treatment with the 3-step acne system (proprietary salicylic acid cleanser 2% twice daily, proprietary salicylic acid toner 2% once daily, and solubilized BPO gel 5% twice daily) or with control cleanser twice daily plus clindamycin 1%-BPO 5% gel (jar formulation) twice daily. Among 139 participants enrolled, the 3-step acne system was at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic (mean reductions were 27% vs 13%, 39% vs 25%, 40% vs 33%, and 42% vs 42% at weeks 2, 4, 6, and 10, respectively)(all not significant). Both regimens were associated with comparable reductions in inflammatory lesion counts at all time points. Both regimens also were generally well-tolerated with mean scores for erythema, dryness, peeling, burning/stinging, and itching less than mild in both groups at all time points. The 3-step acne system is at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic, which is likely attributed to the solubilized BPO formulation.

AB - A 3-step acne system has been developed to enhance the bioavailability and follicular penetration of benzoyl peroxide (BPO). Participants with mild to moderate facial acne vulgaris were randomly assigned to 10 weeks' facial treatment with the 3-step acne system (proprietary salicylic acid cleanser 2% twice daily, proprietary salicylic acid toner 2% once daily, and solubilized BPO gel 5% twice daily) or with control cleanser twice daily plus clindamycin 1%-BPO 5% gel (jar formulation) twice daily. Among 139 participants enrolled, the 3-step acne system was at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic (mean reductions were 27% vs 13%, 39% vs 25%, 40% vs 33%, and 42% vs 42% at weeks 2, 4, 6, and 10, respectively)(all not significant). Both regimens were associated with comparable reductions in inflammatory lesion counts at all time points. Both regimens also were generally well-tolerated with mean scores for erythema, dryness, peeling, burning/stinging, and itching less than mild in both groups at all time points. The 3-step acne system is at least as effective as clindamycin-BPO in reducing noninflammatory lesion counts in the early weeks of treatment in the absence of an antibiotic, which is likely attributed to the solubilized BPO formulation.

UR - http://www.scopus.com/inward/record.url?scp=70349312543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349312543&partnerID=8YFLogxK

M3 - Article

C2 - 19743725

AN - SCOPUS:70349312543

VL - 84

SP - 48

EP - 55

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 1

ER -

Thiboutot D, Eichenfield L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E et al. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. Cutis. 2009 Jul 1;84(1):48-55.